MSD
The Executive Director, Value & Implementation Global Medical & Scientific Affairs (V&I GMSA) leads the global strategic V&I plan for the Chronic Obstructive Pulmonary Disease therapeutic area, allocating equal focus between the United States and the rest of the world. This senior leader drives cross‑functional collaboration, oversees a high‑performing team, manages a multi‑million‑dollar budget, and engages with global scientific leaders, payers, and regulatory stakeholders to advance medical strategy and value generation.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
21% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Executive Director, Value & Implementation Global Medical & Scientific Affairs (V&I GMSA), Global Therapeutic Area (TA)
Merck & Co., Inc.
Executive Director, Global Medical Affairs, GI Oncology
Merck & Co., Inc.
Associate Director, Global Scientific & Value Content - Payor (AD, GSVC-Payor)
Merck & Co., Inc.
Executive Director, Global Medical Affairs, GI Oncology
Merck & Co., Inc.
Director, Global Scientific & Value Content
Merck & Co., Inc.
Global Senior Director Medical Affairs
Merck & Co., Inc.